Alms Therapeutics is a startup based in France, most recent round Seed, 1 tracked investor.
Based in France, Alms Therapeutics is a startup founded in 2017. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Alms Therapeutics is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.